Patrick Vallance to become UK chief scientific adviser

Patrick Vallance, head of research and development at GlaxoSmithKline Plc, is to join the UK government as chief scientific adviser at the end of March 2018. The appointment comes as the UK negotiates its departure from the European Union.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom